Nampt activator-3 |
| Catalog No.GC71068 |
Nampt activator-3NAT 유도체는 EC50은 2.6μM, KD는 132nM의 NAMPT 활성제이다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2790481-63-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
NAMPT activator-3 (compound 72; 0.1, 0.3, 1, 3, 10 μM; 72 hours) exertes no side effect on the cell viability including osteosarcoma cells (U2OS), glioblastoma cells (T98G), neuroblastoma cells (SH-SY5Y) and liver carcinoma cells (HepG2)[1].
NAMPT activator-3 (compound 72) protects peripheral sensory neurons from Taxol -induced damage by enhancing NAD production[1].
Pharmacokinetic Parameters of NAMPT activator-3 in mice[1].
| IV (1 mg/kg) | IP (30 mg/kg) | PO (30 mg/kg) | |
| Tmax (h) | 0.25 | ||
| Cmax (ng/mL) | 1563 | 188 | |
| AUClast (h∗ng/mL) | 183 | 1333 | 388 |
| T1/2 (h) | 0.18 | 1.05 | 1.34 |
| CL (mL/min/kg) | 90.4 | ||
| Vss (mL/kg) | 1130 | ||
| F (%) | 24.2 | 7.05 |
References:
[1]. Leibo Wang, et al. Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy. Eur J Med Chem. 2022 Jun 5;236:114260.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *